Management of recurrent viral hepatitis B and C after liver transplantation
- Cite this article as:
- Montalbano, M. & Neff, G.W. Curr Gastroenterol Rep (2006) 8: 60. doi:10.1007/s11894-006-0065-x
- 26 Views
Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contraindication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment outcomes for HCV and HBV in the period following liver transplant.